Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort study
about
Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinomaMolecular diagnosis and treatment of drug-resistant hepatitis B virus.Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma
P2860
Antiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral drug resistance incr ...... ensated cirrhosis cohort study
@en
Antiviral drug resistance incr ...... nsated cirrhosis cohort study.
@nl
type
label
Antiviral drug resistance incr ...... ensated cirrhosis cohort study
@en
Antiviral drug resistance incr ...... nsated cirrhosis cohort study.
@nl
prefLabel
Antiviral drug resistance incr ...... ensated cirrhosis cohort study
@en
Antiviral drug resistance incr ...... nsated cirrhosis cohort study.
@nl
P2093
P2860
P356
P1476
Antiviral drug resistance incr ...... ensated cirrhosis cohort study
@en
P2093
Chun-Lei Fan
De-Xi Chen
Fei-Li Wei
Hui-Guo Ding
Pei-Ling Dong
Yu-Han Chen
P2860
P304
P356
10.3748/WJG.V19.I45.8373
P407
P577
2013-12-01T00:00:00Z